VHAM
BIIB icon

Van Hulzen Asset Management’s Biogen BIIB Stock Holding History

Van Hulzen Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-749
Closed -$237K – 263
2020
Q1 		$237K Buy
+749
New +$227K 0.05% 213
2019
Q1 		– Sell
-714
Closed -$215K – 237
2018
Q4 		$215K Buy
+714
New +$228K 0.06% 203

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Van Hulzen Asset Management's BIIB Position: Q2 2020 in Review

Van Hulzen Asset Management sold out of Biogen (BIIB) in Q2 2020, closing a stake of 749 shares — an estimated $237K sold.

Van Hulzen Asset Management first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $237K in Q1 2020. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • Van Hulzen Asset Management reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
  • Van Hulzen Asset Management sold 749 Biogen shares in Q2 2020, an estimated $237K.
  • Van Hulzen Asset Management first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • Van Hulzen Asset Management's Biogen position peaked at $237K in Q1 2020.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on Van Hulzen Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.